Direkt zum Inhalt
Merck
  • 5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats.

5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats.

Vascular pharmacology (2015-05-25)
José-Ángel García-Pedraza, Mónica García, María-Luisa Martín, Asunción Morán
ZUSAMMENFASSUNG

Although serotonin has been shown to inhibit peripheral sympathetic outflow, serotonin regulation on renal sympathetic outflow has not yet been elucidated. This study investigated which 5-HT receptor subtypes are involved. Wistar rats were anesthetized (sodium pentobarbital; 60mg/kg, i.p.), and prepared for in situ autoperfused rat kidney, which allows continuous measurement of systemic blood pressure (SBP), heart rate (HR) and renal perfusion pressure (PP). Electrical stimulation of renal sympathetic nerves resulted in frequency-dependent increases in PP (18.3±1.0, 43.7±2.7 and 66.7±4.0 for 2, 4 and 6Hz, respectively), without altering SBP or HR. 5-HT, 5-carboxamidotryptamine (5-HT1/7 agonist) (0.00000125-0.1μg/kg each) or l-694,247 (5-HT1D agonist; 0.0125μg/kg) i.a. bolus inhibited vasopressor responses by renal nerve electrical stimulation, unlike i.a. bolus of agonists α-methyl-5-HT (5-HT2), 1-PBG (5-HT3), cisapride (5-HT4), AS-19 (5-HT7), CGS-12066B (5-HT1B) or 8-OH-DPAT (5-HT1A) (0.0125μg/kg each). The effect of l-694,247 did not affect the exogenous norepinephrine-induced vasoconstrictions, whereas was abolished by antagonist LY310762 (5-HT1D; 1mg/kg) or l-NAME (nitric oxide; 10mg/kg), but not by indomethacin (COX1/2; 2mg/kg) or glibenclamide (ATP-dependent K(+) channel; 20mg/kg). These results suggest that 5-HT mechanism-induced inhibition of rat vasopressor renal sympathetic outflow is mainly mediated by prejunctional 5-HT1D receptors via nitric oxide release.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Salzsäure -Lösung, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
L-Arginin, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-Arginin, reagent grade, ≥98%
Sigma-Aldrich
Salzsäure, 36.5-38.0%, BioReagent, Molecular Biology
Supelco
Salzsäure -Lösung, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
Indomethacin, 98.0-102.0%, meets EP testing specifications
Sigma-Aldrich
Indol, ≥99%
Sigma-Aldrich
L-Arginin, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
Salzsäure -Lösung, for amino acid analysis, ~6 M in H2O
Sigma-Aldrich
Chlorwasserstoff, ReagentPlus®, ≥99%
Sigma-Aldrich
Chlorwasserstoff -Lösung, 3 M in cyclopentyl methyl ether (CPME)
Sigma-Aldrich
L-Arginin, 99%, FCC, FG
SAFC
L-Arginin
Sigma-Aldrich
Salzsäure -Lösung, 32 wt. % in H2O, FCC
Sigma-Aldrich
Atropin -sulfat (Salz) Monohydrat, ≥97% (TLC), crystalline
Sigma-Aldrich
Indomethacin, meets USP testing specifications
Sigma-Aldrich
Indol, ≥99%, FG
Sigma-Aldrich
(±)-8-Hydroxy-2-(dipropylamino)tetralin -hydrobromid, ≥98%
Sigma-Aldrich
Chlormethan -Lösung, 1.0 M in tert-butyl methyl ether, anhydrous
Sigma-Aldrich
Chlormethan -Lösung, 1.0 M in diethyl ether
Sigma-Aldrich
1-Phenylbiguanid, 98%
Sigma-Aldrich
5-Carboxamidotryptamine maleate salt, powder, ≥98% (HPLC)